Description: This 1981 session focused on Reinsurance Trends. Questions included: i. Why the recent movement from YRT to Coinsurance? 2. Should a company use a bulk or self-administered system? 3. When is it advantageous to use Coinsurance or modified coinsurance on existing business? 4. Experimental Underwriting - what are the results? 5. Pricing assumptions - where have all the margins gone? 6. When can reinsurance pools be used effectively what are the pitfalls? 7. What's in the future? a. Use of telecommunications and computers to transfer the risk? b. Lower rates and less service? 8. How have changes in reinsurance pricing affected ceding company pricing?

Description: This 1981 session focused on Reinsurance Trends. Questions included: i. Why the recent movement from YRT to Coinsurance? 2. Should a company use a bulk or self-administered system? 3. When is it advantageous to use Coinsurance or modified coinsurance on existing business for tax planning 4. Experimental Underwriting - what are the results? 5. Pricing assumptions - where have all the margins gone? 6. When can reinsurance pools be used effectively what are the pitfalls? 7. What's in the future? a. Use of telecommunications and computers to transfer the risks? b. Lower rates and less service? 8. How have changes in reinsurance pricing affected ceding company pricing?

Description: A discussion of the recent announcement from FASB that certain reinsurance agreements, such as modified coinsurance arrangements, contain an embedded derivative that must be accounted for in accordance with FASB 133

Description: This session is about regulatory constraints and the role the NAIC is playing to help facilitate 24-hour programs, plan design issues, the use of managed care, coverage as part of a workers' compensation plan versus coverage of health care outside of the workers' compensation system. From Record of Society of Actuaries Vol. 18, No. 4A.

Description: Identifies current trends and considerations when setting the mortality improvement assumption for individual life insurance in the US.

Description: Panelists discuss pricing issues regarding supplemental products, which for this purpose, are defined as cancer, specified disease, student accident, and other special risk accident and health coverages. From the Record of the Society of Actuaries, Vol. 25, No. 2.